TIMELESS and cancer: The current study also demonstrated that combined TRF and TIM knockdown enhanced antitumor efficacy of TRF alone in A549 mouse xenografts, indicating that TRF in combination with TIM inhibition may be a promising strategy to potentiate standard cancer therapies.